USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/28529
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPurteanu Lilia-
dc.contributor.authorGrib Livi-
dc.date.accessioned2024-10-28T12:50:28Z-
dc.date.accessioned2024-11-18T13:40:03Z-
dc.date.available2024-10-28T12:50:28Z-
dc.date.available2024-11-18T13:40:03Z-
dc.date.issued2024-
dc.identifier.citationPurteanu Lilia; Grib Livi. Cardiorenal syndrome. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 107. ISBN 978-9975-3544-2-4.en_US
dc.identifier.isbn978-9975-3544-2-4-
dc.identifier.urihttps://ibn.idsi.md/collection_view/3104-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/28529-
dc.descriptionUniversitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica Moldovaen_US
dc.description.abstractIntroduction. Cardiorenal syndrome (CRS) is a condition characterized by the complex bidirectional relationship between the heart and kidneys, leading to acute or chronic dysfunction of these organs. The relationship between cardiorenal connectors and hemodynamic and nonhemodynamic factors is essential to understanding this syndrome. The clinical importance of these interactions relates to the observed changes in hemodynamic factors, neurohormonal markers, and inflammatory processes. It is a complex disease that is associated with adverse reactions, increased risk of hospitalization, mortality and decreased quality of life. Aim of study. Study of cardiorenal syndrome based on contemporary literature. Methods and materials. A systematic review of the literature was performed using the Medline, PubMed, Scopus and Web of Science databases to identify relevant articles referring to "cardiorenal syndrome", "heart failure" and "chronic kidney disease". Results. This review focuses on the classification and subcategories of the cardiorenal syndrome, the clinical significance of biomarkers in the diagnosis of CRS, and the identification of mechanisms underlying its development and progression. In the end, the review summarizes the available therapeutic options that can improve the survival of patients with CRS and/or mitigate the progression of the disease. Conclusion. Cardiorenal syndrome must be managed appropriately to efficiently reduce mortality and morbidity rates, requiring a strategic, multidisciplinary, multidimensional, and systematic approach. Managing CRS provides valuable perspectives for researchers, healthcare professionals, and decision-makers involved in the complex management and treatment of this condition. bidirectional relationship between the heart and kidneys, l eading to acute or chronic dysfunction of these organs. The relationship between cardiorenal conn ectors and hemodynamic and nonhemodynamic factors is essential to understanding this syndrom e. The clinical importance of these interactions relates to the observed changes in hemodynami c factors, neurohormonal markers, and inflammatory processes. It is a complex disease that i s associated with adverse reactions, increased risk of hospitalization, mortality and decreased quality o f life. Aim of study. Study of cardiorenal syndrome based on contemporary lite rature. Methods and materials. A systematic review of the literature was performed using th e Medline, PubMed, Scopus and Web of Science databases to identify rel evant articles referring to "cardiorenal syndrome", "heart failure" and "chronic kid ney disease". Results. This review focuses on the classification and subcategories of the cardiorenal syndrome, the clinical significance of biomarkers in the diagnosi s of CRS, and the identification of mechanisms underlying its development and progression. In th e end, the review summarizes the available therapeutic options that can improve the survival o f patients with CRS and/or mitigate the progression of the disease. Conclusion. Cardiorenal syndrome must be managed appropriately to eff iciently reduce mortality and morbidity rates, requiring a strategic, multidisciplinar y, multidimensional, and systematic approach. Managing CRS provides valuable perspectives for rese archers, healthcare professionals, and decision-makers involved in the complex management and t reatment of this condition.en_US
dc.publisherInstituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldovaen_US
dc.relation.ispartofMedEspera 2024en_US
dc.subjectheart failureen_US
dc.subjectchronic kidney diseaseen_US
dc.titleCardiorenal syndromeen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2024

Files in This Item:
File Description SizeFormat 
MEsp24_107.pdf347.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback